Latest On Adial Pharmaceuticals, Inc (ADIL):
About Adial Pharmaceuticals, Inc (ADIL):
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of treatment for addictions. Its lead product is AD04, a selective serotonin-3 antagonist for the treatment of alcohol use disorder. The company was founded in 2010 and is based in Charlottesville, Virginia.
General
- Name Adial Pharmaceuticals, Inc
- Symbol ADIL
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 3
- Fiscal Year EndDecember
- IPO Date2018-07-30
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.adialpharma.com
Valuation
- Price/Book (Most Recent Quarter) 6
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.19
- Return on Assets -67%
- Return on Equity -120%
- Earnings Per Share -$1.86
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 39.6 million
- EBITDA -9313408
- Analyst Target Price $5
- Book Value Per Share $0.50
Share Statistics
- Shares Outstanding 15.23 million
- Shares Float 11.79 million
- % Held by Insiders 1753%
- % Held by Institutions 9.82%
- Shares Short 505703
- Shares Short Prior Month 469814
- Short Ratio 0.47
- Short % of Float 4%
- Short % of Shares Outstanding 3%
Technicals
- Beta 0.69
- 52 Week High $3.3
- 52 Week Low $1.01
- 50 Day Moving Average 2.6
- 200 Day Moving Average 2.01
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Adial Pharmaceuticals, Inc (ADIL) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Adial Pharmaceuticals, Inc (ADIL) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-13 | $N/A | -$0.24 | -$0.18 | -33.33% |
2020-06-30 | 2020-08-13 | $N/A | -$0.16 | -$0.18 | 11.11% |
2020-03-31 | 2020-05-14 | $N/A | -$0.22 | ||
2019-12-31 | 2020-03-20 | $N/A | -$0.19 | -$0.19 | 0% |
2019-09-30 | 2019-11-14 | $N/A | -$0.17 | -$0.29 | 41.38% |
2019-06-30 | 2019-08-13 | $N/A | -$0.21 | -$0.23 | 8.7% |
2019-03-31 | 2019-05-13 | $N/A | -$0.33 | -$0.17 | -94.12% |
2018-12-31 | 2019-02-19 | $N/A | -$0.19 | -$0.18 | -5.56% |
2018-09-30 | 2018-11-14 | $N/A | -$1.48 | -$0.26 | -469.23% |
2018-06-30 | 2018-07-30 | $N/A | -$0.27 |
Adial Pharmaceuticals, Inc (ADIL) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Adial Pharmaceuticals, Inc (ADIL) Chart:
Adial Pharmaceuticals, Inc (ADIL) News:
Below you will find a list of latest news for Adial Pharmaceuticals, Inc (ADIL) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Adial Pharmaceuticals, Inc (ADIL) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest ADIL Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 2:52 PM EST | 100 | $1.25 |
Jun 13, 2022 5:26 PM EST | 100 | $1.335 |
Jun 13, 2022 5:43 PM EST | 20 | $1.31 |
Jun 13, 2022 5:43 PM EST | 3 | $1.31 |
Jun 13, 2022 6:20 PM EST | 100 | $1.33 |
Adial Pharmaceuticals, Inc (ADIL) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020016605/0001213900-20-016605-index.htm |
2019-02-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1513525/000000000019001637/0000000000-19-001637-index.htm |
2019-03-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1513525/000000000019006089/0000000000-19-006089-index.htm |
2020-04-27 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1513525/000000000020003603/0000000000-20-003603-index.htm |
2020-07-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1513525/000000000020006125/0000000000-20-006125-index.htm |
2019-03-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1513525/000090266419001327/0000902664-19-001327-index.htm |
2020-01-21 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1513525/000090266420000306/0000902664-20-000306-index.htm |
2020-06-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1513525/000091957420004217/0000919574-20-004217-index.htm |
2018-07-10 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018008954/0001213900-18-008954-index.htm |
2018-07-10 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1513525/000121390018008967/0001213900-18-008967-index.htm |
2018-07-23 | 8-A12B/A | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009518/0001213900-18-009518-index.htm |
2018-07-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009574/0001213900-18-009574-index.htm |
2018-07-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009576/0001213900-18-009576-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009709/0001213900-18-009709-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009711/0001213900-18-009711-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009713/0001213900-18-009713-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009715/0001213900-18-009715-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009717/0001213900-18-009717-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009719/0001213900-18-009719-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009722/0001213900-18-009722-index.htm |
2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009725/0001213900-18-009725-index.htm |
2018-07-30 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390018009822/0001213900-18-009822-index.htm |
2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010083/0001213900-18-010083-index.htm |
2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010085/0001213900-18-010085-index.htm |
2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010087/0001213900-18-010087-index.htm |
2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/0001213900-18-010089-index.htm |
2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010092/0001213900-18-010092-index.htm |
2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010095/0001213900-18-010095-index.htm |
2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010099/0001213900-18-010099-index.htm |
2018-08-16 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1513525/000121390018011309/0001213900-18-011309-index.htm |
2018-09-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390018012298/0001213900-18-012298-index.htm |
2018-09-10 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390018012305/0001213900-18-012305-index.htm |
2018-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390018012880/0001213900-18-012880-index.htm |
2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015546/0001213900-18-015546-index.htm |
2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015548/0001213900-18-015548-index.htm |
2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015554/0001213900-18-015554-index.htm |
2018-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015557/0001213900-18-015557-index.htm |
2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015559/0001213900-18-015559-index.htm |
2018-11-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015600/0001213900-18-015600-index.htm |
2018-11-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015602/0001213900-18-015602-index.htm |
2018-11-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015606/0001213900-18-015606-index.htm |
2018-11-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015610/0001213900-18-015610-index.htm |
2018-11-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390018015655/0001213900-18-015655-index.htm |
2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390018017537/0001213900-18-017537-index.htm |
2018-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390018017831/0001213900-18-017831-index.htm |
2019-01-07 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1513525/000121390019000233/0001213900-19-000233-index.htm |
2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019001194/0001213900-19-001194-index.htm |
2019-01-25 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019001241/0001213900-19-001241-index.htm |
2019-02-12 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002177/0001213900-19-002177-index.htm |
2019-02-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002196/0001213900-19-002196-index.htm |
2019-02-13 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002279/0001213900-19-002279-index.htm |
2019-02-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002312/0001213900-19-002312-index.htm |
2019-02-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002769/0001213900-19-002769-index.htm |
2019-02-19 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002771/0001213900-19-002771-index.htm |
2019-02-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002773/0001213900-19-002773-index.htm |
2019-02-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390019002775/0001213900-19-002775-index.htm |
2019-02-22 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390019003016/0001213900-19-003016-index.htm |
2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019003128/0001213900-19-003128-index.htm |
2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390019004001/0001213900-19-004001-index.htm |
2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390019004003/0001213900-19-004003-index.htm |
2019-03-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019004125/0001213900-19-004125-index.htm |
2019-03-22 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019004699/0001213900-19-004699-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390019004830/0001213900-19-004830-index.htm |
2019-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019004831/0001213900-19-004831-index.htm |
2019-03-29 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005164/0001213900-19-005164-index.htm |
2019-03-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005166/0001213900-19-005166-index.htm |
2019-03-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005178/0001213900-19-005178-index.htm |
2019-04-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005522/0001213900-19-005522-index.htm |
2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005524/0001213900-19-005524-index.htm |
2019-04-02 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005565/0001213900-19-005565-index.htm |
2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019007376/0001213900-19-007376-index.htm |
2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390019008448/0001213900-19-008448-index.htm |
2019-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019011052/0001213900-19-011052-index.htm |
2019-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019012204/0001213900-19-012204-index.htm |
2019-07-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1513525/000121390019012205/0001213900-19-012205-index.htm |
2019-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390019015413/0001213900-19-015413-index.htm |
2019-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019016383/0001213900-19-016383-index.htm |
2019-09-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1513525/000121390019018002/0001213900-19-018002-index.htm |
2019-10-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390019019766/0001213900-19-019766-index.htm |
2019-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019019784/0001213900-19-019784-index.htm |
2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390019023298/0001213900-19-023298-index.htm |
2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390019026186/0001213900-19-026186-index.htm |
2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019026188/0001213900-19-026188-index.htm |
2019-12-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390019027287/0001213900-19-027287-index.htm |
2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020002805/0001213900-20-002805-index.htm |
2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005537/0001213900-20-005537-index.htm |
2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005539/0001213900-20-005539-index.htm |
2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005541/0001213900-20-005541-index.htm |
2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005543/0001213900-20-005543-index.htm |
2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005545/0001213900-20-005545-index.htm |
2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005547/0001213900-20-005547-index.htm |
2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005549/0001213900-20-005549-index.htm |
2020-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005557/0001213900-20-005557-index.htm |
2020-03-20 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1513525/000121390020007020/0001213900-20-007020-index.htm |
2020-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020007568/0001213900-20-007568-index.htm |
2020-03-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020007845/0001213900-20-007845-index.htm |
2020-04-22 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020009839/0001213900-20-009839-index.htm |
2020-04-22 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1513525/000121390020009842/0001213900-20-009842-index.htm |
2020-04-22 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1513525/000121390020009843/0001213900-20-009843-index.htm |
2020-04-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390020010229/0001213900-20-010229-index.htm |
2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390020012328/0001213900-20-012328-index.htm |
2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020013069/0001213900-20-013069-index.htm |
2020-05-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020013162/0001213900-20-013162-index.htm |
2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020013163/0001213900-20-013163-index.htm |
2020-05-22 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390020013332/0001213900-20-013332-index.htm |
2020-05-22 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390020013336/0001213900-20-013336-index.htm |
2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020013504/0001213900-20-013504-index.htm |
2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020014346/0001213900-20-014346-index.htm |
2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020014594/0001213900-20-014594-index.htm |
2020-06-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390020014598/0001213900-20-014598-index.htm |
2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020014671/0001213900-20-014671-index.htm |
2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020014731/0001213900-20-014731-index.htm |
2020-06-17 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020015161/0001213900-20-015161-index.htm |
2020-06-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1513525/000121390020015264/0001213900-20-015264-index.htm |
2020-07-02 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020016605/0001213900-20-016605-index.htm |
2020-07-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1513525/000121390020016969/0001213900-20-016969-index.htm |
2020-07-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390020017356/0001213900-20-017356-index.htm |
2020-07-21 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1513525/000121390020018019/0001213900-20-018019-index.htm |
2020-07-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020018048/0001213900-20-018048-index.htm |
2020-07-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1513525/000121390020019495/0001213900-20-019495-index.htm |
2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020019496/0001213900-20-019496-index.htm |
2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020020540/0001213900-20-020540-index.htm |
2020-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1513525/000121390020021918/0001213900-20-021918-index.htm |
2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020023494/0001213900-20-023494-index.htm |
2020-08-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020023564/0001213900-20-023564-index.htm |
2020-09-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020024915/0001213900-20-024915-index.htm |
2020-09-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1513525/000121390020026280/0001213900-20-026280-index.htm |
2020-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020027253/0001213900-20-027253-index.htm |
2020-09-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020027649/0001213900-20-027649-index.htm |
2020-09-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020027739/0001213900-20-027739-index.htm |
2020-09-25 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1513525/000121390020028472/0001213900-20-028472-index.htm |
2020-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020028582/0001213900-20-028582-index.htm |
2020-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020029096/0001213900-20-029096-index.htm |
2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020029425/0001213900-20-029425-index.htm |
2020-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020032495/0001213900-20-032495-index.htm |
2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1513525/000121390020034675/0001213900-20-034675-index.htm |
2018-07-27 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1513525/000135445718000288/0001354457-18-000288-index.htm |
2018-07-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999518001892/9999999995-18-001892-index.htm |
2018-07-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999518002166/9999999995-18-002166-index.htm |
2019-02-20 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999519000305/9999999995-19-000305-index.htm |
2019-04-01 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999519000565/9999999995-19-000565-index.htm |
2020-04-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999520000864/9999999995-20-000864-index.htm |
2020-04-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999520000871/9999999995-20-000871-index.htm |
2020-04-30 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999520000938/9999999995-20-000938-index.htm |
2020-07-10 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1513525/999999999520001774/9999999995-20-001774-index.htm |
Adial Pharmaceuticals, Inc (ADIL) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adial Pharmaceuticals, Inc (ADIL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1753%Institutional Ownership: 982%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-07-31 | James W. Jr. Newman | Director | Buy | 10,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/0001213900-18-010089-index.htm | ||
2020-08-20 | Bankole A. Johnson | Chief Medical Officer | Sell | 350,000.00 | 1.21 | 423,500.00 | 1,055.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020023494/0001213900-20-023494-index.htm |
2020-03-03 | Joseph Truluck | Chief Financial Officer | Buy | 27,084.00 | 107,639.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005543/0001213900-20-005543-index.htm | ||
2018-07-31 | Robertson H. Gilliland | Director | Buy | 14,000.00 | 109,424.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010083/0001213900-18-010083-index.htm | ||
2020-03-27 | James W. Jr. Newman | Director | Buy | 10,000.00 | 1.34 | 13,400.00 | 13,288.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020007845/0001213900-20-007845-index.htm |
2018-07-31 | Bankole A. Johnson | Director | Buy | 1,400.00 | 1,400.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010087/0001213900-18-010087-index.htm | ||
2020-03-27 | James W. Jr. Newman | Director | Buy | 4,644.00 | 1.35 | 6,269.40 | 14,644.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020007845/0001213900-20-007845-index.htm |
2020-03-27 | James W. Jr. Newman | Director | Buy | 5,000.00 | 1.42 | 7,100.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020007845/0001213900-20-007845-index.htm |
2018-07-31 | James W. Jr. Newman | Director | Buy | 10,000.00 | 150,419.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010089/0001213900-18-010089-index.htm | ||
2018-07-31 | Bankole A. Johnson | Director | Buy | 40,382.00 | 313,750.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010087/0001213900-18-010087-index.htm | ||
2019-03-28 | Bankole A. Johnson | Chief Medical Officer | Buy | 40,000.00 | 3.15 | 125,808.00 | 314,768.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005524/0001213900-19-005524-index.htm |
2018-07-31 | Kevin Schuyler | Director | Buy | 90,000.00 | 343,390.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010092/0001213900-18-010092-index.htm | ||
2019-03-29 | Bankole A. Johnson | Chief Medical Officer | Buy | 30,000.00 | 3.47 | 104,154.00 | 344,768.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005524/0001213900-19-005524-index.htm |
2019-03-29 | Bankole A. Johnson | Chief Medical Officer | Buy | 2,500.00 | 3.47 | 8,669.00 | 347,268.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005524/0001213900-19-005524-index.htm |
2019-03-29 | Bankole A. Johnson | Chief Medical Officer | Buy | 600.00 | 3.30 | 1,978.02 | 347,868.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019005524/0001213900-19-005524-index.htm |
2019-10-02 | Bankole A. Johnson | Chief Medical Officer | Buy | 3,187.00 | 351,055.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019019766/0001213900-19-019766-index.htm | ||
2018-07-31 | William B. III Stilley | Chief Executive Officer | Buy | 80,000.00 | 504,000.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010095/0001213900-18-010095-index.htm | ||
2020-03-03 | William B. III Stilley | Chief Executive Officer | Buy | 54,167.00 | 690,937.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390020005545/0001213900-20-005545-index.htm | ||
2019-12-12 | Bankole A. Johnson | Chief Medical Officer | Sell | 150,000.00 | 1.00 | 150,000.00 | 698,336.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390019026186/0001213900-19-026186-index.htm |
2018-07-31 | Tony Goodman | Director | Buy | 7,000.00 | 8,755.00 | https://www.sec.gov/Archives/edgar/data/1513525/000121390018010085/0001213900-18-010085-index.htm |